A Close Examination of Patient Experiences in Bipolar Disorder Clinical Trials
- Conditions
- Bipolar Disorder
- Registration Number
- NCT05891639
- Lead Sponsor
- Power Life Sciences Inc.
- Brief Summary
Participation in clinical trials usually favors a particular demographic group. But there is limited research available to explain what study attributes affect the completion of these specific demographic groups.
This study will investigate the safety and efficacy of bipolar disorder treatments. The focus will be on tracking the rates of completion and withdrawal among these individuals.
It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future bipolar disorder study.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 500
- Patient is at least 18 years of age
- Diagnosis of bipolar disorder
- Ability to understand a written informed consent document, and the willingness to sign it.
- Women of childbearing potential without a negative pregnancy test; or women who are lactating.
- Has a serious medical or psychiatric illness likely to interfere with participation in this clinical study.
- Inability to perform regular electronic reporting
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Rate of bipolar disorder patients who decide to enroll in a clinical research. 3 months Number of bipolar disorder study participants who remain in clinical research until completion. 12 months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Power Life Sciences
🇺🇸San Francisco, California, United States